Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 726.5 DKK 4.23% Market Closed
Market Cap: 51.5B DKK
Have any thoughts about
Zealand Pharma A/S?
Write Note

EV/S
Enterprise Value to Sales

562.3
Current
85.7
Median
7.7
Industry
Higher than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
562.3
=
Enterprise Value
43.2B DKK
/
Revenue
76.9m DKK
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
259.1
2-Years Forward
EV/S
58.4
3-Years Forward
EV/S
21.1

See Also

Discover More